Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. OVID
OVID logo

OVID News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

OVID News

Wedbush Reiterates Ovid Therapeutics at Outperform with $7 Price Target

Apr 08 2026NASDAQ.COM

Ovid Therapeutics Stock Surges 18% on Positive OV329 Data

Mar 18 2026Fool

Ovid Therapeutics' OV329 Shows Promising Safety and Efficacy in Phase 1 Study

Mar 18 2026NASDAQ.COM

Coherent Corp. Shares Rise 6% Ahead of OFC 2026 Showcase

Mar 18 2026NASDAQ.COM

Health Care Stocks Decline in Premarket Trading

Mar 18 2026Yahoo Finance

Ovid Therapeutics Shares Surge 26% on Positive Clinical Data and Financing

Mar 18 2026NASDAQ.COM

Ovid Therapeutics Shares Surge Over 40% on Positive OV329 Drug Results

Mar 18 2026seekingalpha

Ovid Therapeutics Advances KCC2 Oral Activator OV4071 Clinical Trial Plans

Dec 18 2025Newsfilter

OVID Events

04/21 16:40
Ovid Therapeutics Files to Sell 29.86M Shares of Common Stock
Ovid Therapeutics files to sell 29.86M shares of common stock for holders

OVID Monitor News

Ovid Therapeutics Shares Surge on Positive OV329 Drug Results

Mar 18 2026

OVID Earnings Analysis

No Data

No Data

People Also Watch